Company research / PEN

Penumbra Inc (PEN)

CIK 0001321732 · NYSE · Surgical & Medical Instruments & Apparatus

  • Sector Manufacturing
  • Incorporated DE
  • Fiscal year ends Dec 31

For the year ended 2025-12-31, Penumbra Inc reported revenue of $1.40B. Revenue grew 17.5% from the prior annual period. Over the twelve months to 2026-06-30, revenue was $1.50B.

Key ratios (year ended 2025-12-31)

67.1%
Gross margin
13.5%
Operating margin
12.7%
Net margin
12.4%
Return on year-end equity
17.5%
Revenue growth (YoY)

Beyond the statements

Follow the company.

Explore new filings, reported insider transactions and company relationships.

Open company research ↗

Latest selected filing: Form 4 (ownership change) · 2026-10-16

Headquarters locality: Alameda · View on map

Annual financials

Annual flows and balances are grouped by their actual period end. Select a figure to open its SEC filing. n/a means a matching observation is unavailable. Free cash flow is operating cash flow minus capital expenditures, and EBITDA is operating income plus depreciation and amortization, for the same period, computed by TickerFacts.

The first column covers the twelve months to 2026-06-30 from the latest quarterly report: flows are the last fiscal year plus this year to date minus the same months a year earlier, and balances are as of that date. Per-share figures are annual only.

Period endedTTM to
2026-06-30
2025-12-312024-12-312023-12-312022-12-312021-12-312020-12-312019-12-312019-06-302018-12-312017-12-31
Revenue$1.50B$1.40B$1.19B$1.06B$847.13M$747.59M$560.41M$547.40Mn/a$444.94M$333.76M
Cost of Revenue$483.98M$461.23M$439.62M$375.88M$311.93M$272.21M$222.24M$175.44Mn/a$152.41M$116.62M
Gross Profit$1.02B$942.44M$755.00M$682.64M$535.21M$475.38M$338.18M$371.96Mn/a$292.53M$217.14M
R&D Expense$92.25M$89.77M$94.78M$84.42M$79.41M$104.55M$90.05M$51.72Mn/a$36.16M$31.66M
Operating Income$187.34M$189.25M$9.28M$73.55M$6.08M-$7.50M-$38.94M$47.51Mn/a-$852.0K$1.17M
Depreciation & Amortization$17.14M$17.47M$23.70M$27.26M$24.32M$16.41M$12.89M$8.10Mn/a$6.17M$3.78M
EBITDA$204.48M$206.72M$32.98M$100.81M$30.40M$8.91M-$26.05M$55.61Mn/a$5.32M$4.95M
Net Income$160.59M$177.69M$14.01M$90.95M-$2.00M$5.28M-$15.70M$48.46Mn/a$6.60M$4.66M
EPS (Diluted)n/a$4.52$0.36$2.32-$0.05$0.14-$0.44$1.34n/a$0.18$0.13
Total Assets$1.97B$1.83B$1.53B$1.56B$1.37B$1.24B$822.98M$665.90Mn/a$515.01M$476.67M
Total Liabilities$443.96M$398.92M$382.25M$377.36M$372.03M$290.32M$185.19M$180.29Mn/a$92.59M$76.26M
Shareholders' Equity$1.53B$1.43B$1.15B$1.18B$998.86M$953.93M$641.50M$485.89Mn/a$422.24M$400.41M
Cash & Equivalents$205.27M$186.90M$324.40M$167.49M$69.86M$59.38M$69.67M$72.78Mn/a$67.85M$50.64M
Operating Cash Flow$277.80M$238.66M$168.48M$97.33M-$55.66M$9.50M-$33.24M$26.65Mn/a$28.81M$12.69M
Capital Expenditures$61.90M$63.73M$21.18M$15.21M$19.30M$21.18M$24.76M$22.11Mn/a$9.60M$12.53M
Free Cash Flow$215.91M$174.93M$147.30M$82.12M-$74.96M-$11.68M-$58.00M$4.54Mn/a$19.20M$159.0K
Share Repurchasesn/a$0$100.39M$0$0n/an/an/an/an/an/a
Shares Outstandingn/a39.23M38.49M38.68M38.11M37.58M36.41M35.00M34.44M34.44M33.69M
Weighted Average Diluted Sharesn/a39.29M39.27M39.22M37.84M37.88M35.77M36.27Mn/a36.09M35.32M
EPS (Basic)n/a$4.57$0.36$2.37-$0.05$0.14-$0.44$1.39n/a$0.19$0.14

Price chart

Chart and quotes by TradingView. Exchange coverage and delays vary.

Open chart on TradingView